Quarterly report pursuant to Section 13 or 15(d)

SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.20.2
SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Jan. 17, 2019
Allowance for doubtful accounts $ 0   $ 0   $ 0  
Grant funding during the first year           $ 2,842,430
Grant funding during the second year           $ 2,831,838
Impairment of acquired license     0 $ 0    
Advertising costs 109,141 $ 88,514 371,265 155,474    
Research and development expenses 1,289,366 298,263 3,344,970 579,366    
Deferred income     370,023      
Revenue related to access fees     13,500      
Payment on accounts receivable     $ 41,329      
Discount rate on face value     8.00%      
Grant income $ 1,392,632 $ 230,373 $ 3,498,084 $ 582,169    
Grant funds     $ 3,909,436      
Royalty obligations description     The Company accounted for royalty obligations as debt in accordance with ASC 470-10-25 and derived a debt discount, which is amortized using the effective interest method over the expected life of the arrangement, which is 15 years. The Company has no obligation to repay the then outstanding balance if during the expected life of 15 years the treatment is discontinued.      
Royalty obligations, net     $ 7,171,200      
Minimum [Member]            
Property plant and equipment estimated useful lives     5 years      
Maximum [Member]            
Property plant and equipment estimated useful lives     15 years